Annual D&A
$1.37 M
+$199.00 K+16.98%
31 December 2023
Summary:
Taysha Gene Therapies annual depreciation & amortization is currently $1.37 million, with the most recent change of +$199.00 thousand (+16.98%) on 31 December 2023. During the last 3 years, it has risen by +$1.36 million (+15133.33%). TSHA annual D&A is now at all-time high.TSHA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$294.00 K
-$28.00 K-8.70%
30 September 2024
Summary:
Taysha Gene Therapies quarterly depreciation & amortization is currently $294.00 thousand, with the most recent change of -$28.00 thousand (-8.70%) on 30 September 2024. Over the past year, it has dropped by -$37.00 thousand (-11.18%). TSHA quarterly D&A is now -19.67% below its all-time high of $366.00 thousand, reached on 31 December 2023.TSHA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.31 M
-$37.00 K-2.75%
30 September 2024
Summary:
Taysha Gene Therapies TTM depreciation & amortization is currently $1.31 million, with the most recent change of -$37.00 thousand (-2.75%) on 30 September 2024. Over the past year, it has dropped by -$60.00 thousand (-4.39%). TSHA TTM D&A is now -4.67% below its all-time high of $1.37 million, reached on 31 December 2023.TSHA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | -11.2% | -4.4% |
| 3 y3 years | +10000.0% | +77.1% | +352.3% |
| 5 y5 years | - | - | - |
TSHA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -19.7% | +77.1% | -4.7% | +352.3% |
| 5 y | 5 years | at high | >+9999.0% | -19.7% | -4.7% | ||
| alltime | all time | at high | >+9999.0% | -19.7% | -4.7% |
Taysha Gene Therapies Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $294.00 K(-8.7%) | $1.31 M(-2.8%) |
| June 2024 | - | $322.00 K(-0.9%) | $1.34 M(-1.5%) |
| Mar 2024 | - | $325.00 K(-11.2%) | $1.36 M(-0.4%) |
| Dec 2023 | $1.37 M(+17.0%) | $366.00 K(+10.6%) | $1.37 M(+0.3%) |
| Sept 2023 | - | $331.00 K(-3.5%) | $1.37 M(+4.1%) |
| June 2023 | - | $343.00 K(+3.6%) | $1.31 M(+5.6%) |
| Mar 2023 | - | $331.00 K(-8.6%) | $1.24 M(+6.1%) |
| Dec 2022 | $1.17 M | $362.00 K(+30.7%) | $1.17 M(+15.0%) |
| Sept 2022 | - | $277.00 K(+1.5%) | $1.02 M(+12.2%) |
| June 2022 | - | $273.00 K(+5.0%) | $908.00 K(+26.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $260.00 K(+24.4%) | $720.00 K(+46.3%) |
| Dec 2021 | $492.00 K(+5366.7%) | $209.00 K(+25.9%) | $492.00 K(+70.2%) |
| Sept 2021 | - | $166.00 K(+95.3%) | $289.00 K(+129.4%) |
| June 2021 | - | $85.00 K(+165.6%) | $126.00 K(+207.3%) |
| Mar 2021 | - | $32.00 K(+433.3%) | $41.00 K(+355.6%) |
| Dec 2020 | $9000.00 | - | - |
| Dec 2020 | - | $6000.00(+100.0%) | $9000.00(+200.0%) |
| Sept 2020 | - | $3000.00(>+9900.0%) | $3000.00(>+9900.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
FAQ
- What is Taysha Gene Therapies annual depreciation & amortization?
- What is the all time high annual D&A for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual D&A year-on-year change?
- What is Taysha Gene Therapies quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly D&A year-on-year change?
- What is Taysha Gene Therapies TTM depreciation & amortization?
- What is the all time high TTM D&A for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM D&A year-on-year change?
What is Taysha Gene Therapies annual depreciation & amortization?
The current annual D&A of TSHA is $1.37 M
What is the all time high annual D&A for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual depreciation & amortization is $1.37 M
What is Taysha Gene Therapies annual D&A year-on-year change?
Over the past year, TSHA annual depreciation & amortization has changed by +$199.00 K (+16.98%)
What is Taysha Gene Therapies quarterly depreciation & amortization?
The current quarterly D&A of TSHA is $294.00 K
What is the all time high quarterly D&A for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly depreciation & amortization is $366.00 K
What is Taysha Gene Therapies quarterly D&A year-on-year change?
Over the past year, TSHA quarterly depreciation & amortization has changed by -$37.00 K (-11.18%)
What is Taysha Gene Therapies TTM depreciation & amortization?
The current TTM D&A of TSHA is $1.31 M
What is the all time high TTM D&A for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM depreciation & amortization is $1.37 M
What is Taysha Gene Therapies TTM D&A year-on-year change?
Over the past year, TSHA TTM depreciation & amortization has changed by -$60.00 K (-4.39%)